In this specialisation, you’ll look at a cell as one big and complex system. You’ll study epigenetic mechanisms during development and disease from different angles. This includes studying DNA and RNA by next-generation sequencing (epigenomics) and analyzing proteins by mass spectrometry (proteomics). In addition, you‘ll be trained to design computational strategies that allow the integration of these multifaceted, high-throughput data sets into one system. You will learn how to work with state-of-the-art technology in combination with biological software tools to study complete networks in cells in an unbiased manner.

Radboud University integrates various state-of-the-art technologies – such as quantitative mass spectrometry and next-generation DNA sequencing – with downstream bioinformatics analyses. This is unique in Europe. This programme allows you to work with researchers from the Radboud Institute for Molecular Life Sciences (RIMLS), one of the leading multidisciplinary research institutes within this field of study worldwide. We have close contacts with high-profile medically oriented groups on the Radboud campus and with international institutes (EMBL, Max-Planck, Marie Curie, Cambridge, US-based labs, etc). As a Master’s student, there is ample opportunity to perform an internship in one of these groups. Radboud University coordinates multiple large epigenetics projects, including projects on leukaemia, skin development, pluripotency, embryonic development, malaria, and organoids. Master’s students have the opportunity to participate in these projects.

Facts and figures

• Degree: MSc in Medical Biology
• Faculty: Faculty of Science
• Croho code: 60610
• Duration: 2 years (120 EC), full time
• Start month: September
• Language of instruction: English
• Enrolled students: 30 - 50 per year
• Contact hours: 20 -30 hours per week

Master's in Medical Epigenomics: something for you?

• Radboud Institute for Molecular Life Sciences (RIMLS) is world-leading in studying the epigenome.
• We offer state-of-the-art technologies with downstream bioinformatics analyses in one department, which is unique in Europe.
• We have close contacts with high-profile medical groups on our campus and with international institutes.
• Do your internship in one of our large epigenetics projects, including projects on leukaemia, skin development, pluripotency, embryonic development, malaria, and organoids.

Why study Medical Epigenomics at Radboud University?

• Radboud University integrates various state-of-the-art technologies – such as quantitative mass spectrometry and next-generation DNA sequencing – with downstream bioinformatics analyses. This is unique in Europe.
• This programme allows you to work with researchers from the Radboud Institute for Molecular Life Sciences (RIMLS), one of the leading multidisciplinary research institutes within this field of study worldwide.
• We have close contacts with high-profile medically oriented groups on the Radboud campus and with international institutes (EMBL, Max-Planck, Marie Curie, Cambridge, US-based labs, etc). As a Master’s student, there is ample opportunity to perform an internship in one of these groups.
• Radboud University coordinates multiple large epigenetics projects, including projects on leukaemia, skin development, pluripotency, embryonic development, malaria, and organoids. Master’s students have the opportunity to participate in these projects.
• Researchers that are trained to generate and integrate high-dimensional data are in high demand both in the academia and in the industry. Many of our former students are pursuing their PhD studies in renowned institutions.